- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 18 residues within 4Å:- Chain A: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106, S.272
- Chain H: M.111, P.112
- Ligands: MG.1
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:G.74, A:S.75, A:G.76, A:G.76, A:K.77, A:T.78, A:S.79, A:Q.106
- Water bridges: A:L.22
- Salt bridges: A:K.77, A:K.77
- pi-Stacking: A:F.43
ATP.5: 16 residues within 4Å:- Chain A: M.111, P.112
- Chain B: W.14, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.4
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:G.74, B:G.74, B:S.75, B:G.76, B:G.76, B:K.77, B:T.78, B:T.78, B:S.79, B:Q.106
- Water bridges: B:L.22, B:E.23, B:S.186
- Salt bridges: B:K.77, B:K.77
ATP.8: 18 residues within 4Å:- Chain C: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106, S.272
- Chain F: M.111, P.112
- Ligands: MG.7
12 PLIP interactions:12 interactions with chain C- Hydrogen bonds: C:G.74, C:S.75, C:G.76, C:G.76, C:K.77, C:T.78, C:S.79, C:Q.106
- Water bridges: C:L.22
- Salt bridges: C:K.77, C:K.77
- pi-Stacking: C:F.43
ATP.11: 16 residues within 4Å:- Chain C: M.111, P.112
- Chain D: W.14, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.10
15 PLIP interactions:15 interactions with chain D- Hydrogen bonds: D:G.74, D:G.74, D:S.75, D:G.76, D:G.76, D:K.77, D:T.78, D:T.78, D:S.79, D:Q.106
- Water bridges: D:L.22, D:E.23, D:S.186
- Salt bridges: D:K.77, D:K.77
ATP.14: 18 residues within 4Å:- Chain D: M.111, P.112
- Chain E: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106, S.272
- Ligands: MG.13
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:T.73, E:G.74, E:S.75, E:G.76, E:G.76, E:K.77, E:T.78, E:S.79, E:Q.106
- Water bridges: E:L.22
- Salt bridges: E:K.77, E:K.77
- pi-Stacking: E:F.43
ATP.17: 16 residues within 4Å:- Chain E: M.111, P.112
- Chain F: W.14, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.16
16 PLIP interactions:16 interactions with chain F- Hydrogen bonds: F:T.73, F:G.74, F:G.74, F:S.75, F:G.76, F:G.76, F:K.77, F:T.78, F:S.79, F:Q.106
- Water bridges: F:L.22, F:E.23, F:E.23, F:S.186
- Salt bridges: F:K.77, F:K.77
ATP.20: 18 residues within 4Å:- Chain B: M.111, P.112
- Chain G: W.14, L.22, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106, S.272
- Ligands: MG.19
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:T.73, G:G.74, G:S.75, G:G.76, G:G.76, G:K.77, G:T.78, G:S.79, G:Q.106
- Water bridges: G:L.22
- Salt bridges: G:K.77, G:K.77
- pi-Stacking: G:F.43
ATP.23: 16 residues within 4Å:- Chain G: M.111, P.112
- Chain H: W.14, E.23, E.38, V.41, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.22
16 PLIP interactions:16 interactions with chain H- Hydrogen bonds: H:T.73, H:G.74, H:G.74, H:S.75, H:G.76, H:G.76, H:K.77, H:T.78, H:S.79, H:Q.106
- Water bridges: H:L.22, H:E.23, H:E.23, H:S.186
- Salt bridges: H:K.77, H:K.77
- 8 x ACY: ACETIC ACID(Non-functional Binders)
ACY.3: 8 residues within 4Å:- Chain A: L.154, G.155, E.156, G.158, V.159, T.160, L.161
- Chain F: L.191
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain F- Hydrophobic interactions: A:E.156, F:L.191
- Hydrogen bonds: A:E.156, A:G.158, A:V.159, A:T.160, A:T.160, A:L.161
ACY.6: 8 residues within 4Å:- Chain B: L.154, G.155, E.156, G.158, V.159, T.160, L.161
- Chain E: L.191
7 PLIP interactions:6 interactions with chain B, 1 interactions with chain E- Hydrogen bonds: B:E.156, B:G.158, B:V.159, B:T.160, B:T.160, B:L.161
- Hydrophobic interactions: E:L.191
ACY.9: 8 residues within 4Å:- Chain C: L.154, G.155, E.156, G.158, V.159, T.160, L.161
- Chain H: L.191
8 PLIP interactions:1 interactions with chain H, 7 interactions with chain C- Hydrophobic interactions: H:L.191, C:E.156
- Hydrogen bonds: C:E.156, C:G.158, C:V.159, C:T.160, C:T.160, C:L.161
ACY.12: 8 residues within 4Å:- Chain D: L.154, G.155, E.156, G.158, V.159, T.160, L.161
- Chain G: L.191
7 PLIP interactions:6 interactions with chain D, 1 interactions with chain G- Hydrogen bonds: D:E.156, D:G.158, D:V.159, D:T.160, D:T.160, D:L.161
- Hydrophobic interactions: G:L.191
ACY.15: 8 residues within 4Å:- Chain B: L.191
- Chain E: L.154, G.155, E.156, G.158, V.159, T.160, L.161
8 PLIP interactions:7 interactions with chain E, 1 interactions with chain B- Hydrophobic interactions: E:E.156, B:L.191
- Hydrogen bonds: E:E.156, E:G.158, E:V.159, E:T.160, E:T.160, E:L.161
ACY.18: 8 residues within 4Å:- Chain A: L.191
- Chain F: L.154, G.155, E.156, G.158, V.159, T.160, L.161
7 PLIP interactions:6 interactions with chain F, 1 interactions with chain A- Hydrogen bonds: F:E.156, F:G.158, F:V.159, F:T.160, F:T.160, F:L.161
- Hydrophobic interactions: A:L.191
ACY.21: 8 residues within 4Å:- Chain D: L.191
- Chain G: L.154, G.155, E.156, G.158, V.159, T.160, L.161
8 PLIP interactions:7 interactions with chain G, 1 interactions with chain D- Hydrophobic interactions: G:E.156, D:L.191
- Hydrogen bonds: G:E.156, G:G.158, G:V.159, G:T.160, G:T.160, G:L.161
ACY.24: 8 residues within 4Å:- Chain C: L.191
- Chain H: L.154, G.155, E.156, G.158, V.159, T.160, L.161
7 PLIP interactions:1 interactions with chain C, 6 interactions with chain H- Hydrophobic interactions: C:L.191
- Hydrogen bonds: H:E.156, H:G.158, H:V.159, H:T.160, H:T.160, H:L.161
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ACY: ACETIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B